YMI: No, GQ, nothing material. but i think it is still cheap.
I have not sold single share yet.
Just think about it, INCy has market cap of 2 B plus, YMI has market cap of less than 200 M till today! YMI definately has better product than INCy in the sense that it does not worsens anemia, in fact it improves anemia response which is big deal for MF patients. I think patience is the key with this one.
It might go to 1 dollars tomorrow if something bad happens , as anything is possible in biotechs, but i like what i see and i am not selling it below 3 or before partnership or buy out announcement! Go to street.com and read AF's article. Nomrally he is very harsh with biotechs, even he is bullish with this one.
DILUTION: VERY MUCH POSSIBLE. I PUT 33 % POSSIBILITY OF ALL THREE, PARTNERSHIP/BUYOUT/DILUTION.
EVEN IF THEY DILUTE LONG TERM PROSPECTES ARE NOT GOING TO CHANGE.
YESTERDAY VOLUE WAS 4.2 m . TODAY IT IS 1.5 M WITH ONE HOUR OF TRADING LEFT. IT HAS NOT GIVEN UP YESTERDAYS MASSIVE GAIN TODAY!
News Breaks
January 23, 2012
09:16 EDT YMI
theflyonthewall.com: YM Biosciences reported compelling data, says Roth Capital
Roth Capital believes that YM reported differentiated efficacy data, especially with regard to positive anemia responses, at ASH. The firm thinks that the company will land a major partnership n 1H12 and it reiterates a $6 target and Buy rating on the stock.
